Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This broad category encompasses a diverse array of proteins responsible for the regulation and transduction of calcium (Ca2+) signals, which serve as a primary second messenger in nearly all eukaryotic cells [1]. Calcium-selective ion channels, including voltage-gated calcium channels (VGCCs) and store-operated channels like ORAI1, facilitate the controlled entry of Ca2+ into the cytoplasm from the extracellular environment or internal stores such as the endoplasmic reticulum [2]. Once intracellular Ca2+ levels rise, physiological calcium-binding proteins (CaBPs) like calmodulin, troponin C, and parvalbumin act as either sensors that trigger downstream biological effects or buffers that shape the spatio-temporal dynamics of the calcium signal [3]. These proteins are fundamental to critical processes such as cardiac and skeletal muscle contraction, neurotransmitter release in the central nervous system, and the regulation of gene transcription [4]. Due to their central role in physiology, they are major therapeutic targets; for instance, calcium channel blockers are a cornerstone in treating hypertension and arrhythmias, while gabapentinoids target specific calcium channel subunits to manage neuropathic pain and epilepsy [5]. Dysregulation of these systems is linked to a wide spectrum of pathologies, including heart failure, neurodegeneration, and malignant hyperthermia [6]. (Citations: [1] UniProt Calcium-binding; [2] IUPHAR/BPS Guide to Pharmacology; [3] PubMed PMC3073433; [4] StatPearls Calcium Channel Blockers; [5] NIH/NCBI Gene Database; [6] Nature Reviews Drug Discovery).
Inhibition of calcium ion influx through voltage-gated or ligand-gated channels; modulation of intracellular calcium release from the sarcoplasmic reticulum; buffering of cytosolic calcium concentrations to regulate signaling cascades.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological calcium-binding proteins and calcium-selective ion channels (CaBPs and Ca2+ channels).